Table 1

Specific 3H-nemonapride binding after 8 mo treatment with typical and atypical antipsychotics

ControlHaloperidol (1.5 mg/kg/day)Raclopride (10 mg/kg/day)Clozapine (25 mg/kg/day)
Caudate-putamen
 Medial part75.5  ± 3.8118.2  ± 5.91-a 99.9  ± 5.11-a 85.3  ± 6.5
(+57%) (+32%)
 Lateral part97.9  ± 5.2147.0  ± 8.31-a 128.1  ± 5.81-a 109.2  ± 8.9
(+50%) (+31%)
Cortex
 Dorsolateral frontal7.0  ± 0.76.0  ± 0.88.9  ± 1.06.6  ± 0.7
 Medial prefrontal8.7  ± 0.88.5  ± 0.68.5  ± 0.49.3  ± 0.3
Nucleus accumbens86.7  ± 4.4152.2  ± 8.81-a 116.1  ± 7.51-a 95.2  ± 4.5
(+75%) (+34%)
  • Data (mean ± S.E.M.) expressed in fmol/mg tissue,n = 6/group.

  • 1-a Values significantly different from control (P < .05, Dunnett t test).